Turkish Journal of Gastroenterology
Original Article

Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in patients with familial Mediterranean fever

1.

Department of Internal Medicine, GATA Haydarpaşa Training Hospital, İstanbul, Turkey

2.

Department of Gastroenterology, GATA Haydarpaşa Training Hospital, İstanbul, Turkey

3.

Department of Gastroenterology, Çanakkale State Hospital, Çanakkale, Turkey

4.

Department of Biochemistry, GATA Haydarpaşa Training Hospital, İstanbul, Turkey

5.

Department of Gastroenterology, Gülhane Military Medical Academy, Ankara, Turkey

Turk J Gastroenterol 2015; 26: 487-491
DOI: 10.5152/tjg.2015.0223
Read: 58 Downloads: 5 Published: 25 July 2019

Abstract

Background/Aims: Serum matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) are well-known inflammatory biomarkers, with a diagnostic potential for various diseases. The aim of the present study was to determine the potential diagnostic applications of serum MMP-9 and TIMP-1 concentrations in patients with familial Mediterranean fever (FMF). 

 

Materials and Methods: A total of 66 male FMF patients and 40 age-matched healthy subjects were included in this research. TIMP-1 and MMP-9 levels with conventional inflammation markers were determined. Pearson correlation analysis was used to determine the correlation between the characteristics of patients and the laboratory data.

 

Results: In patients with FMF, serum MMP-9 levels and MMP-9/TIMP-1 ratios were found to be significantly elevated in both acute episode and asymptomatic periods (p=0.0001 and p=0.0001, respectively). There was no significant difference between TIMP-1 levels. A significant negative correlation between patients’ current age and TIMP-1 level in patients with acute episodes was detected (p=0.0008, r=−0.52). Moreover, a moderate negative correlation was noticed between erythrocyte sedimentation rate and TIMP-1 level in patients with acute episodes (p=0.01, r=−0.39). Additionally, a moderate negative correlation was found between the duration of colchicine use and MMP-9 and TIMP-1 levels during the attack period (p=0.04, r=−0.36 and p=0.02, r=−0.39, respectively).

 

Conclusion: Our findings demonstrate that a significant MMP-9/TIMP-1 imbalance exists in patients with FMF, which reflects an ongoing inflammation in both FMF periods. Thus, the increased MMP-9 levels observed in FMF patients could rationalize therapeutic targeting to MMPs.

Files
EISSN 2148-5607
3